In humans, the tumor microenvironment is typically more complex, comprising various immunosuppressive cells and factors (e.g., regulatory T cells, tumor-associated macrophages, TGF-β, etc.)(40), which may further compromise CAR-T cell efficacy. The gene discussed is TGFB1; the disease is neoplasm.